Saturday, October 25, 2014 Cincinnati, Ohio
Faculty

Symposium Director

Henry A. Nasrallah, MD
The Sydney W. Souers Professor and Chair
Department of Neurology and Psychiatry
Saint Louis University School of Medicine
St. Louis, Missouri
Dr. Henry Nasrallah is professor and chairman of the Department of Neurology and Psychiatry at Saint Louis University, and holds the Sydney W. Souers Endowed Chair. He is a widely recognized neuropsychiatrist, educator and researcher. Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the NIH, he served as chair of the Ohio State University Department of Psychiatry for twelve years. In January 2003, he joined the University of Cincinnati College of Medicine as Associate Dean and Professor of Psychiatry and Neuroscience. In October 2013, he joined St. Louis University to chair the integrated Department of Neurology and Psychiatry.
Dr. Nasrallah's research focuses on the neurobiology and psychopharmacology of schizophrenia and related psychoses. He has published 380 scientific articles, 440 abstracts, as well as 11 books. He is Editor-In-Chief of two journals (SCHIZOPHRENIA RESEARCH and CURRENT PSYCHIATRY) and is the co-founder of the Schizophrenia International Research Society (SIRS). He is board certified in in adult psychiatry. He is a fellow in the American College of Neurpsychopharmacology (ACNP) a distinguished fellow of the American Psychiatric Association (APA) , and has served as president of the Cincinnati Psychiatric Society and as president of the American Academy of Clinical Psychiatrists. He has twice received the NAMI Exemplary Psychiatrist Award and was chosen as the U.S.A. Teacher of the Year by the Psychiatric Times. He has received over 90 research grants and is listed in all editions of the book "Best Doctors in America".

2014 Faculty

Karl Doghramji, MD
Professor of Psychiatry, Neurology, and Medicine
Medical Director, Jefferson Sleep Disorders Center
Program Director, Fellowship in Sleep Medicine
Thomas Jefferson University
Philadelphia, PA
Dr. Doghramji is a professor and director of the Sleep Disorders Center at Thomas Jefferson University Hospital in Philadelphia. He has held numerous committee positions with the American Academy of Sleep Medicine and has served as an examiner for the American Board of Psychiatry and Neurology and the American Board of Sleep Medicine. He has authored more than 150 journal publications and book chapters and has edited and written 3 books. He has been the recipient of numerous grants. His published works and research focus on a wide variety of sleep disorders, including excessive daytime somnolence, sleep apnea syndrome, and insomnia, as well as depression and anxiety disorders.
Mark S. Gold, MD
Retired University of Florida Distinguished Professor
Donald R. Dizney Eminent Scholar
Professor and Chairman, Department of Psychiatry (1990-2014)
Alachua, FL
Dr. Gold was the 17th University of Florida's Distinguished Alumni Professor. Prior to assuming the position as Professor & Chair which he held until July, 2014 he was a Distinguished Service Professor in the Departments of Psychiatry, Neuroscience, Anesthesiology, and Community Health and Family Medicine at the University of Florida College of Medicine located in Gainesville, Florida. Dr. Gold is a teacher of the year, researcher and inventor who has worked for over 40 years to develop models for understanding the effects of tobacco, cocaine , and other drugs and also food on the brain and behavior. Dr. Gold has developed translational research models which have led to new treatments for addicts and also conceptualized hypotheses which were more than novel but also yielded new approaches to treat patients. He has been recognized many times for his innovations and also as an inventor.

Dr. Gold's pioneering work on the brain systems underlying the effects of opiate drugs led to a dramatic change in the way opiate action was understood. He proposed a novel model for opiate action, dependence, and withdrawal. This locus coeruleus theory of opiate and drug withdrawal is a mainstay of 2013 theory and practice, even though he proposed it in 1978. Gold was then the senior author on the discovery paper and was awarded a patent for the discovery of new uses for clonidine (Catapres) which remains widely used for opiate withdrawal and pain management. Dr. Gold and Herbert Kleber were the first to suggest sequential use of clonidine and Naltrexone as well as, rapid detoxification and also post-detox maintenance with Naltrexone. During the mid-1980s Gold and colleagues developed a new theory for cocaine action, cocaine dependence, and cocaine withdrawal in the dopamine-rich areas of the brain. While most at the time did not consider cocaine addictive because of the lack of a classic withdrawal syndrome, Gold proposed a dopamine theory of pathological attachment, loss of control and addiction. Gold's original work on cocaine led to a complete change in thinking about cocaine's addiction liability, acute and chronic actions. This work re-defined addiction and moved the field toward fatal attraction, brain hijacking and loss of control rather than abstinence symptom or signs basis. He helped focus and mentor many researchers and clinicians on dopamine and deficiency states, including current NIDA Director Nora Volkow, M.D. The dopamine hypothesis and the role of dopamine in drug reinforcement are the mainstay of current drug addiction theory. Gold also had the first report of crack, cocaine smoking in the literature. This dopamine work, published first in 1984 and again in 1985 by Gold and Dackis remains seminal and are considered by many classic examples of translational science. In addition to theory, Dr. Gold's research has laid the foundation for the subsequent studies cementing the neuroanatomy of withdrawal and also dependence or addiction. His work reduced stigma and changed treatment. Dr. Gold has been listed as one of the Best Doctors® in America, U.S. News Best Doctors , and Addiction Editor for more than a decade, of Addiction Medicine for the nation's number one textbook of medicine, UpToDate.

Dr Gold started physicians treatment and outcomes research with clonidine and naltrexone in 1978 but has continued this work. He continues as a leader in addiction treatment and treatment research, especially in work related to impaired health professionals. This work, which started in Florida, has become a national focus with Tom McLellan, Ph.D. and Bob Dupont, M.D. reporting the national outcomes of impaired health professionals and suggesting that this model be applied more broadly to addiction treatment.

Over the past two decades, Dr. Gold has pioneered the hypothesis of hedonic overeating or pathological attachment to food as an addiction. This work is much less controversial now that many recognize the similarities between great food and compulsive overeating and other process addictions such as gambling and sex. Drs. Brownell and Gold are the Editors of "Food Addiction", the highly acclaimed textbook published by Oxford University Press. Gold has mentored many of the nation's current leaders in overeating, eating disorders and addiction in prevention, education and research.

Dr Gold has regularly been a major contributor to the US's national drug strategy, advisor, participant in consensus panels, and with the National Institutes. Dr. Gold has worked with the Hillary Clinton's State Department on the Children of Kabul project and presented these and other findings at national, international, and UN meetings. This work, which has been highlighted by Secretary Clinton on the State Department web site, is continuing. Most recently, he has received a 30 year of service award from the DEA for his work in education and prevention.

Since beginning his career in research, he has been the author of over 900 medical articles, chapters, and abstracts in journals for health professionals on a wide variety of psychiatric research subjects and authoring twelve professional books including practice guidelines, ASAM core competencies, and medical text books for primary care professionals. He is the author of 15 general audience books. According to a review in the Journal of the American Medical Association (JAMA 272:18, 1996), "Mark S. Gold, M.D. the most prolific and brilliant of the addiction experts writing today. Dr. Gold has spent his career trying to bridge the gap in medical education and practice with the belief that addictions are diseases and that all physicians have a critical role in prevention and, if that fails, in early identification and prompt treatment."
Joseph F. Goldberg, MD
Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York
Director, Affective Disorders Research Program
Silver Hill Hospital,
New Canaan, CT
Dr. Goldberg is a psychiatrist with 25 years of experience in academic research studying the features and treatment of mood disorders, particularly bipolar disorder and other forms of depression. He supervises and teaches psychopharmacology to medical students and residents at the Mount Sinai School of Medicine, and maintains a private practice in Norwalk, CT. He has published over 160 original research publications in major psychiatric journals on topics related to mood disorders, focusing on the use of anticonvulsant mood stabilizers and atypical antipsychotics, safety risks with antidepressants in bipolar disorder, management of drug side effects, features related to rapid cycling bipolar disorder, suicide risk in bipolar disorder, cognitive dysfunction in bipolar disorder, pharmacogenetics in bipolar disorder, comorbid psychiatric disorders in bipolar disorder, and the long-term functional course and outcome of bipolar disorder and depression.
Wayne K. Goodman, MD
Professor and Chair, Psychiatry
Professor, Neuroscience
Icahn School of Medicine
Chief of the Division of Tics, OCD, and Related Disorders (DTOR)
Chairman, Department of Psychiatry
Mount Sinai School of Medicine
New York, NY
On July 1, 2009, Dr. Goodman was appointed Professor and Chairman of the Department of Psychiatry at the Mount Sinai School of Medicine in New York City. He is the Esther and Joseph Klingenstein Professor of Psychiatry and Professor in the Department of Neuroscience

Prior to joining Mt. Sinai, he served as Director, Division of Adult Translational Research and Treatment Development (DATR), at the National Institute of Mental Health in Bethesda, Maryland from 2007-2009. He has conducted pioneering research in the field of Obsessive-Compulsive Disorder (OCD) and is the principal developer of the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), the gold standard for assessing OCD. He is co-founder of the Obsessive Compulsive Foundation, the national patient advocacy organization for this disorder.

As Chair of Psychiatry, Dr. Goodman works closely with the new Mount Sinai Brain Institute to conduct research on neuropsychiatric disorders such as schizophrenia, Alzheimer’s disease, and mood disorders.

Dr. Goodman is an expert psycho-pharmacologist who previously served as Chair of the Food and Drug Administration’s (FDA's) Psychopharmacologic Drug Advisory Committee.

His primary areas of research interest are obsessive compulsive disorder (OCD) and related disorders such as Tourette’s Syndrome (TS) in children and adults. He is interested in advancing the treatment of OCD through a better understanding of its pathophysiology. During a span of 20 years, he has investigated the phenomenology, neurobiology and treatment of OCD. In recent years, he has focused on developing approaches to treatment-resistant OCD including the study of Deep Brain Stimulation (DBS).
John M. Oldham, MD, MS
Past President
American Psychiatric Association
Chief of Staff
The Menninger Clinic
Houston, Texas
Dr. Oldham leads the medical staff and oversees research at the Menninger Clinic, while at Baylor College of Medicine, he oversees clinical care, including the public psychiatry division of Harris County Hospital District and The Baylor Psychiatry Clinic. He is also the host of Mindscape, a podcast series about mental health issues.

An expert in personality disorders and recognized internationally as a leader in psychiatric medicine, Dr. Oldham is board certified in psychiatry, psychoanalysis and forensic psychiatry.

Throughout his career, Dr. Oldham has been active in the American Psychiatric Association, which serves more than 38,000 psychiatrists worldwide. He is a past president of the organization. Dr. Oldham has also served a two-year term as president of the American College of Psychiatrists.

Before joining Menninger in 2007, he served as professor and chairman of Psychiatry & Behavioral Sciences and executive director of the Institute of Psychiatry at the Medical University of South Carolina.

At Columbia University, Dr. Oldham was the Elizabeth K. Dollard Professor and acting chairman of the Department of Psychiatry. He also directed the New York State Psychiatric Institute and was chief medical officer of the New York State Office of Mental Health.

Dr. Oldham received his medical degree from Baylor College of Medicine and completed psychiatric residency training at Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute. He completed psychoanalytic training at the Columbia Psychoanalytic Center.
Murray B. Stein MD, MPH
Professor of Psychiatry and Family and Preventive Medicine
Director, Anxiety & Traumatic Stress Disorders Program
University of California San Diego
La Jolla, CA
Dr. Stein is Professor of Psychiatry and Family & Preventive Medicine at the University of California San Diego (UCSD), where he directs the Anxiety & Traumatic Stress Disorders Program. Dr. Stein graduated from the University of Manitoba and completed his residency and post-residency fellowship at the University of Toronto and at the National Institute of Mental Health in Bethesda, Maryland, USA. He subsequently completed a Master of Public Health degree at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland.

Dr. Stein’s research interests include the epidemiology, neurobiology, and treatment of anxiety disorders especially social phobia, panic disorder, and posttraumatic stress disorder. He has written or co-written over 400 peer-reviewed scientific articles on these topics, including in journals such as The Lancet, Journal of the American Medical Association, American Journal of Psychiatry, and Archives of General Psychiatry. He is co-editor, with Martin Antony PhD, of the Oxford Handbook of Anxiety and Related Disorders (2009). His federally funded research has included studies of interventions for anxiety disorders in primary care, pharmacological approaches to treatment-resistant anxiety disorders, and functional neuroimaging research in anxiety and trauma-related disorders. He is Principal Investigator and Director of the Department of Defense-funded (2008-2013) INjury and TRaumatic STress (INTRuST) Consortium, which studies treatments for Posttraumatic Stress Disorder and Traumatic Brain Injury. He is also Co-Principal Investigator (with Robert Ursano MD) of Army STARRS, an NIMH-funded project (2009-2014) investigating risk factors for suicide and other deployment-related disorders.